Platelet 3H-imipramine binding during recovery from depression.
Decreased binding of tritiated imipramine to platelets has been considered to be a potential biological marker of depression. However, it has been unclear how binding values alter during treatment and recovery. This study investigated imipramine binding parameters and depressive symptoms in 25 patients suffering from major depression at entry to the study and 1, 3 and 6 months later. Although the initial Bmax values were significantly lower in the depressed patients than in healthy subjects, it was not possible to establish a clear relationship between recovery from depression and Bmax. The power of this study to detect an effect of at least 10% of the variance in Bmax due to factors related to recovery from depression was 0.78.
Ellis
P M
PM
Department of Psychological Medicine, Wellington School of Medicine, University of Otago, New Zealand.
Beeston
R
R
McIntosh
C J
CJ
Salmond
C E
CE
Cooke
R R
RR
D000328:Adult; D003866:Depressive Disorder / Q000097:blood*; D005260:Female; D006801:Humans; D007099:Imipramine / Q000378:metabolism*; D008137:Longitudinal Studies; D008297:Male; D010973:Platelet Adhesiveness / Q000187:drug effects*
D007099:Imipramine